The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats

MLA

Chengda Ren, et al. “The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats.” Journal of Ophthalmology, vol. 2017, Jan. 2017. EBSCOhost, https://doi.org/10.1155/2017/6145651.

APA

Chengda Ren, Hui Shi, Juanjuan Jiang, Qingyu Liu, Yaru Du, Mengmei He, Wenting Cai, Qingquan Wei, & Jing Yu. (2017). The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats. Journal of Ophthalmology, 2017. https://doi.org/10.1155/2017/6145651

Chicago

Chengda Ren, Hui Shi, Juanjuan Jiang, Qingyu Liu, Yaru Du, Mengmei He, Wenting Cai, Qingquan Wei, and Jing Yu. 2017. “The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats.” Journal of Ophthalmology 2017 (January). doi:10.1155/2017/6145651.